DavidAShaywitzMDPhD

Summary

• Dr. David Shaywitz is a physician-executive focused on the application of emerging technologies to biopharma and functional longevity. He pursued his MD/PhD at Harvard Medical School/MIT, continued his training in internal medicine and endocrinology at the Massachusetts General Hospital, and completed his post-doctoral fellowship in the Melton Lab at the Harvard Stem Cell Institute.
  
  He works at the intersection of biopharma, AI, and digital health, helping organizations navigate the rapid evolution of emerging technologies and translate breakthroughs into real-world impact. His career has been built on identifying high-value innovations, connecting biopharma and tech, and guiding scientific and technological advances toward practical application in drug development, healthcare, and human performance.
  
  As a physician-scientist and biopharma executive, he has worked across strategy, external innovation, investment, and digital transformation -- with a pragmatic focus on adoption and tangible patient benefit. He has partnered with startups, pharma leaders, and investors to help them integrate AI, wearables, and data-driven technologies into implementable solutions that advance R&D, enhance patient care, and promote functional longevity.